Patents by Inventor Paul McGee

Paul McGee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Polymorph forms of desazadesferrithiocin analogs
    Patent number: 9512095
    Abstract: The present invention provides a solid form and compositions thereof, which are useful as metal chelators and which exhibit desirable characteristics for the same.
    Type: Grant
    Filed: March 13, 2014
    Date of Patent: December 6, 2016
    Assignee: FERROKIN BIOSCIENCES, INC.
    Inventors: Srini Tenjarla, Paul McGee
  • POLYMORPH FORMS OF DESAZADESFERRITHIOCIN ANALOGS
    Publication number: 20160024034
    Abstract: The present invention provides a solid form and compositions thereof, which are useful as metal chelators and which exhibit desirable characteristics for the same.
    Type: Application
    Filed: March 13, 2014
    Publication date: January 28, 2016
    Inventors: Srini Tenjarla, Paul McGee
  • Process for the preparation of anagrelide and analogues thereof
    Patent number: 9067944
    Abstract: The present invention relates to a novel process for producing anagrelide, 6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin 2(3H)-one, or certain analogs thereof. The process of the invention also provides improved processes for producing key intermediates required for the synthesis of anagrelide or certain analogs thereof.
    Type: Grant
    Filed: October 21, 2011
    Date of Patent: June 30, 2015
    Assignee: SHIRE LLC
    Inventor: Paul McGee
  • PROCESS FOR THE PREPARATION OF ANAGRELIDE AND ANALOGUES THEREOF
    Publication number: 20130211083
    Abstract: The present invention relates to a novel process for producing anagrelide, 6,7-dichloro-1,5-dihydroimidazo[2,1-b]quinazolin 2(3H)-one, or certain analogues thereof. The process of the invention also provides improved processes for producing key intermediates required for the synthesis of anagrelide or certain analogues thereof.
    Type: Application
    Filed: October 21, 2011
    Publication date: August 15, 2013
    Applicant: SHIRE LLC
    Inventor: Paul McGee
  • PROCESS FOR THE SYNTHESIS OF PRODRUGS OF OPIOIDS
    Publication number: 20120165520
    Abstract: The present invention provides a process for the synthesis of opioid prodrugs. In particular, the present invention provides a process for the synthesis of opioid prodrugs comprising: treating an opioid, in the form of a salt or a freebase, with a carbonyl synthon to form an activated intermediate and subsequently reacting the activated intermediate with an amine, in the form of a salt or a freebase.
    Type: Application
    Filed: December 22, 2011
    Publication date: June 28, 2012
    Inventors: Paul McGee, Ian Garnett, E. Juan, A. Manage, Jean-Francois Carniaux
  • MEPTAZINOL CARBAMATE PRODRUG SALTS
    Publication number: 20120165315
    Abstract: The present invention relates to salts of meptazinol carbamate prodrugs, and to their synthesis and use.
    Type: Application
    Filed: December 22, 2011
    Publication date: June 28, 2012
    Inventors: Paul McGee, R. Melling, Jean-Luc Coudret, A. Manage, Jean-Francois Camiaux, Colin Lindley
  • Controlled release galantamine composition
    Patent number: 7160559
    Abstract: The present invention is concerned with controlled release compositions for oral administration comprising galantamine; and with processes of preparing such controlled release compositions.
    Type: Grant
    Filed: December 20, 1999
    Date of Patent: January 9, 2007
    Assignee: Janssen Pharmaceutica N.V.
    Inventors: John Paul McGee, Paul Marie Victor Gilis, Marc Maurice Germain De Weer, Valentin Florent Victor de Condé, Herman Johannes Catherina de Bruijn, Frederic Anne Rodolf Van Dycke